ClearPoint Neuro Inc. logo

ClearPoint Neuro Inc.

CLPT | NASDAQ
Chart Builder DCF Calculator
$15.03
+$1.06 (+7.59%)
Sep 22, 2026, 2:01 PM ET · Market open

Company Profile

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Key Executives

Name Position
Joseph Michael Burnett President, Chief Executive Officer & Director
Danilo D'Alessandro Chief Financial Officer
Mazin Sabra Chief Operating Officer
Ellisa Cholapranee General Counsel & Secretary
Jeremy Stigall Chief Business Officer
Mary McNamara-Cullinane Senior Vice President of Regulatory Affairs
Megan Faulkenberry Senior Vice President of Quality
Paul S. Larson FAANS Chief Medical Officer
Robert C. Korn Senior Vice President of Sales & Business Development

Latest SEC Filings

Date Type Title
Sep 03, 2026 4 Filing
Aug 12, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 04, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 03, 2026 10-Q Quarterly Report
Aug 03, 2026 8-K Current Report
Jul 27, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jul 06, 2026 4 Filing
Jul 06, 2026 4 Filing
Jul 02, 2026 4 Filing
Jul 02, 2026 4 Filing
View All SEC Filings
ClearPoint Neuro Inc.
ClearPoint Neuro Inc. logo
Country United States
IPO Date May 21, 2012
Industry Medical - Devices
Sector Healthcare
Employees 172
CEO Joseph Michael Burnett

Contact Details

120 S. Sierra Avenue Solana Beach, California 92075 United States

Stock Details

Ticker Symbol CLPT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001285550
CUSIP Number 18507C103
ISIN Number US18507C1036
SIC Code 3841

© 2026 bestshares.com. All rights reserved.